Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 351 | 0 | 0 | 0 | 0 |
| Gross Profit | 351 | N/A | N/A | N/A | N/A |
| Operating Expenses | 22,828 | 24,881 | 27,236 | 28,836 | 29,170 |
| Operating Income | -22,477 | -24,881 | -27,236 | -28,836 | -29,170 |
| Other Income | 30,681 | 5,026 | 59,918 | 13,199 | -21,865 |
| Pre-tax Income | 8,204 | -19,855 | 32,682 | -15,637 | -51,035 |
| Net Income Continuous | 8,204 | -19,855 | 32,682 | -15,637 | -51,035 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | 139,811 |
| Net Income | $8,204 | $-19,855 | $32,682 | $-15,637 | $88,776 |
| EPS Basic Total Ops | 0.94 | -2.27 | 3.76 | -1.80 | 11.63 |
| EPS Basic Continuous Ops | 0.94 | -2.27 | 3.76 | -1.55 | -6.69 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.25 | 18.32 |
| EPS Diluted Total Ops | 0.94 | -2.27 | 3.75 | -1.80 | 11.63 |
| EPS Diluted Continuous Ops | 0.94 | -2.27 | 3.75 | -1.55 | -6.69 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.25 | 18.32 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.27 | -2.24 | N/A | -6.60 |
| EBITDA(a) | $-21,433 | $-23,822 | $-26,160 | $-27,751 | $-27,303 |